Jakarta (ANTARA) – The Health Ministry is distributing additional 13 million doses of COVID-19 vaccines from various manufacturers to several regions across Indonesia, according to an official.
“In the near future, local governments will receive deliveries of more than 13 million doses,” the ministry’s acting Director General for Pharmacy and Medical Devices, Arianti Anaya, stated in a virtual press conference here on Tuesday.
As of Monday (Aug 23), the government has dispatched a total of 130.3 million COVID-19 doses, of which some 116.4 million doses, or 85 percent, were distributed to the regions.
The vaccines comprise 4.8 million doses of the CoronaVac vaccine bought from China’s Sinovac, 85.9 million doses of CoronaVac but produced by Bandung-based Bio Farma that established cooperation with Sinovac, 1.5 million doses of the Pfizer vaccine, 15.9 million doses of AstraZeneca vaccine, 77.5 million doses of Moderna vaccine, and 499,886 doses of the Sinopharm vaccine.
Arianti noted that the government had maintained a stock of 5.8 million doses of the COVID-19 vaccine for immediate distribution to the regions.
“This vaccine stock has just arrived. Hence, if it just arrived, of course, it cannot be distributed immediately, as they must be given numbers first in Indonesia. However, it only takes a few days, and we will immediately distribute it,” she stated.
A total of 8.1 million doses of the government’s vaccine quota stock are in the delivery stage to local government facilities, she noted.
“This is something we need to be grateful for, as we want to speed up the vaccination process across Indonesia,” she remarked.
Until the end of 2021, the estimated number of vaccines that Indonesia will receive will continue to increase.
“Later, from August, September, October, November, and December, we will receive quite a lot of vaccines of various brands,” she noted.
The vaccines come from manufacturers, such as AstraZeneca, Sinovac, Novavax, Pfizer, and Moderna, provided under the COVAC Facility mechanism.
In August 2021, the government is targeting the availability of 67.6 million doses of vaccine from various sources: 19.8 million doses of Bio Farma, 25 million doses of Coronavac, 15.9 million vaccine doses from Covax facilities, 2.2 million doses of the AstraZeneca vaccine under bilateral cooperation, 1.5 million doses of Pfizer vaccine under the bilateral cooperation scheme, 2.5 million vaccine doses under the bilateral grant, and 0.5 million doses of Sinopharm vaccine.
“In September 2021, the government targets to obtain additional stocks, specifically around 80.7 million vaccine doses from various sources that are sufficient to be used, with a vaccination rate of two million per day,” she noted.
Source: Antara News
